I'm riding: PTC Classic

Team: Team Accenture

ID: 104016

Lifetime total: $10157.0000

Start time: 10:15 am - Wave 5


In late March, 2017, I was diagnosed with stage 4 Pancreatic Cancer. At the age of 50 (and completely healthy otherwise), this diagnosis caught me completely by surprise, and turned my life upside down in an instant. I had surgery to remove many tumors (and a good portion of my intestines) and started chemo treatments in Sydney, Australia where I was living at the time. In July, 2017 I moved back to the St. Louis area with my wife and three children continuing my treatment at the Siteman Cancer Center. I am very impressed with the treatment approach, the doctors, nurses and staff at Siteman. We are truly blessed to have a world class cancer facility in our city as you never know when you or a family member will need it.

After a rough period this winter where my disease progressed rendering my digestive system non-functional, I am now on a stable path forward. In March, 2018 I started TPN (IV nutrition) for all my calories, and my health has stabilized. Having endured a 40 pound weight loss and 5 trips to the hospital, I am now training for this year's ride as I need to rebuild my strength. In spite of these setbacks, I am committed to participating in this year's ride. Last year I rode the 20 mile route and this year I plan to do the same. I can no longer eat or drink anything other than sips of water, but the nutrition from the TPN provides 2000 calories a day. While not an ideal situation, I am very thankful for the medical advances that allows me to live a somewhat normal life in spite of these circumstances.

I am proud to join Pedal the Cause in the fight against cancer. Pedal the Cause is more than the region's top cycling event. It's a way of life, a celebration, and a movement fueled by the courage to end cancer.

It takes world-class research to create a world without cancer. Please help me in this journey by donating to my ride, and give with confidence knowing that 100% of your donation will go directly to accelerating cancer research at Siteman Cancer Center and St. Louis Children's Hospital.